Remove DNA Remove Drug Development Remove Pharma Companies
article thumbnail

UK Pharma Company Scancell Selects COVID-19 Vaccine for Clinical Trials | 2020-12-21

The Pharma Data

UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.

article thumbnail

#Unshackled: The evolving definition of asset-centricity

DrugBaron

Buoyed by the string of successes in early discovery delivered by this approach, attention inevitably turned to how we might leverage the same insights to improve return on capital in the rest of the long path through drug development. In practice, this looks much more like a traditional pharma company than a biotech.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to find a drug: the past, present and future of small molecule drug discovery?

DrugBaron

Constructing larger and more diverse screening libraries was, for a while, the competitive advantage of the largest pharma companies. The first is the growing popularity of DNA-encoded libraries (DELs). Two solutions, one physical and one computational have emerged.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Srinivasan has led the development of multiple computational pipelines to process data from different next generation sequencing techniques with applications in oncology, genome editing systems including CRISPR-Cas mediated DNA editing, and ADAR-mediated RNA editing. big pharma or startups/spin off? What pro/cons?

article thumbnail

First in Human Episode #54 featuring Ahmed Hamdy

Vial

Also, payloads that are permeable payloads and specifically microtubule inhibitors or DNA alkylators or chemo. Rich McCormick: Drug development can be quite challenging. Rich McCormick: How do you strike a balance between the clinical aspects and the commercial demands in your role as the CEO of a pharma company?

article thumbnail

Scaling Phage Therapy

Codon

Various algorithms, trained on data from enormous databases of phages and bacteria, have been developed to predict phage-host relationships in silico rather than find them experimentally with lab work. Middle and Right) Once a bacteriophage lands on a cell, it injects its DNA through a tube (purple) into the unwilling host.

Therapies 135